A Prediction Model for Detecting Dysthyroid Optic Neuropathy Based on Clinical Factors and Imaging Markers of the Optic Nerve and Cerebrospinal Fluid in the Optic Nerve Sheath

Abstract

Objective

This study aimed to develop and test a model for predicting dysthyroid optic neuropathy (DON) based on clinical factors and imaging markers of the optic nerve and cerebrospinal fluid (CSF) in the optic nerve sheath.

Methods

This retrospective study included patients with thyroid-associated ophthalmopathy (TAO) without DON and patients with TAO accompanied by DON at our hospital. The imaging markers of the optic nerve and CSF in the optic nerve sheath were measured on the water-fat images of each patient and, together with clinical factors, were screened by Least absolute shrinkage and selection operator. Subsequently, we constructed a prediction model using multivariate logistic regression. The accuracy of the model was verified using receiver operating characteristic curve analysis.

Results

In total, 80 orbits from 44 DON patients and 90 orbits from 45 TAO patients were included in our study. Two variables (optic nerve subarachnoid space and the volume of the CSF in the optic nerve sheath) were found to be independent predictive factors and were included in the prediction model. In the development cohort, the mean area under the curve (AUC) was 0.994, with a sensitivity of 0.944, specificity of 0.967, and accuracy of 0.901. Moreover, in the validation cohort, the AUC was 0.960, the sensitivity was 0.889, the specificity was 0.893, and the accuracy was 0.890.

Conclusions

A combined model was developed using imaging data of the optic nerve and CSF in the optic nerve sheath, serving as a noninvasive potential tool to predict DON.

References

[1] KhongJJ, FinchS, De SilvaC, et al.. Risk Factors for Graves’ Orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study. J Clin Endocrinol Metab, 2016, 101(7): 2711-2720

[2] BartalenaL, WiersingaWM, PincheraA. Graves’ ophthalmopathy: state of the art and perspectives. J Endocrinol Invest, 2004, 27(3): 295-301

[3] NeigelJM, RootmanJ, BelkinRI, et al.. Dysthyroid Optic Neuropathy. Ophthalmology, 1988, 95(11): 1515-1521

[4] McKeagD, LaneC, LazarusJH, et al.. Clinical features of dysthyroid optic neuropathy: a European Group on Graves’ Orbitopathy (EUGOGO) survey. Br J Ophthalmol, 2007, 91(4): 455-458

[5] NugentRA, BelkinRI, NeigelJM, et al.. Graves orbitopathy: correlation of CT and clinical findings. Radiology, 1990, 177(3): 675-682

[6] SaeedP, Tavakoli RadS, BisschopPHLT. Dysthyroid Optic Neuropathy. Ophthalmic Plast Reconstr Surg, 2018, 34(4SSuppl1): S60-S67

[7] RiemannCD, FosterJA, KosmorskyGS. Direct orbital manometry in patients with thyroid-associated orbitopathy. Ophthalmology, 1999, 106(7): 1296-1302

[8] Perez-LopezM, Sales-SanzM, RebolledaG, et al.. Retrobulbar ocular blood flow changes after orbital decompression in Graves’ ophthalmopathy measured by color Doppler imaging. Invest Ophthalmol Vis Sci, 2011, 52(8): 5612-5617

[9] SoniCR, JohnsonLN. Visual Neuropraxia and Progressive Vision Loss from Thyroid-Associated Stretch Optic Neuropathy. Eur J Ophthal, 2010, 20(2): 429-436

[10] DoddsNI, AtchaAW, BirchallD, et al.. Use of high-resolution MRI of the optic nerve in Graves’ ophthalmopathy. Br J Radiol, 2009, 82(979): 541-544

[11] Rutkowska-HincB, MajE, JablonskaA, et al.. Prevalence of Radiological Signs of Dysthyroid Optic Neuropathy in Magnetic Resonance Imaging in Patients with Active, Moderate-to-Severe, and Very Severe Graves Orbitopathy. Eur Thyroid J, 2018, 7(2): 88-94

[12] KaichiY, TanitameK, ItakuraH, et al.. Orbital Fat Volumetry and Water Fraction Measurements Using T2-Weighted FSE-IDEAL Imaging in Patients with Thyroid-Associated Orbitopathy. AJNR Am J Neuroradiol, 2016, 37(11): 2123-2128

[13] DasT, RoosJCP, PattersonAJ, et al.. T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study. Eye (Lond), 2019, 33(2): 235-243

[14] ReederSB, PinedaAR, WenZ, et al.. Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): application with fast spin-echo imaging. Magn Reson Med, 2005, 54(3): 636-644

[15] YuH, ReederSB, ShimakawaA, et al.. Field map estimation with a region growing scheme for iterative 3-point water-fat decomposition. Magn Reson Med, 2005, 54(4): 1032-1039

[16] BartleyGB, GormanCA. Diagnostic Criteria for Graves’ Ophthalmopathy. Am J Ophthalmol, 1995, 119(6): 792-795

[17] WuH, LuoB, YuanG, et al.. The diagnostic value of the IDEAL-T2WI sequence in dysthyroid optic neuropathy: a quantitative analysis of the optic nerve and cerebrospinal fluid in the optic nerve sheath. Eur Radiol, 2021, 31(10): 7419-7428

[18] HumbertIA, ReederSB, PorcaroEJ, et al.. Simultaneous estimation of tongue volume and fat fraction using IDEAL-FSE. J Magn Reson Imaging, 2008, 28(2): 504-508

[19] OllitraultA, CharbonneauF, HerdanML, et al.. Dixon-T2WI magnetic resonance imaging at 3 tesla outperforms conventional imaging for thyroid eye disease. Eur Radiol, 2021, 31(7): 5198-5205

[20] CostaDN, PedrosaI, McKenzieC, et al.. Body MRI using IDEAL. AJR Am J Roentgenol, 2008, 190(4): 1076-1084

[21] NardoL, KarampinosDC, LansdownDA, et al.. Quantitative assessment of fat infiltration in the rotator cuff muscles using water-fat MRI. J Magn Reson Imaging, 2014, 39(5): 1178-1185

[22] NedergaardM, GoldmanSA. Glymphatic failure as a final common pathway to dementia. Science, 2020, 370(6512): 50-56

[23] MathieuE, GuptaN, AhariA, et al.. Evidence for Cerebrospinal Fluid Entry Into the Optic Nerve via a Glymphatic Pathway. Invest Ophthalmol Vis Sci, 2017, 58(11): 4784-4791

[24] MathieuE, GuptaN, Paczka-GiorgiLA, et al.. Reduced Cerebrospinal Fluid Inflow to the Optic Nerve in Glaucoma. Invest Ophthalmol Vis Sci, 2018, 59(15): 5876-5884

[25] SuzukiH, OkuH, HorieT, et al.. Changes in expression of aquaporin-4 and aquaporin-9 in optic nerve after crushing in rats. PLoS One, 2014, 9(12): e114694

[26] LambinP, Rios-VelazquezE, LeijenaarR, et al.. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer, 2012, 48(4): 441-446